Esophageal Squamous Cell Carcinoma Abdominal Stage 0
1 clinical trials · Condition
◉ Watch Esophageal Squamous Cell Carcinoma Abdominal Stage 0
| Record | Firm | Date |
|---|---|---|
| PD-1 Antibody Combined With mXELIRI Versus mXELIRI in the Second-line Setting for ESCC (NCT05737563) | Sun Yat-sen University | 2023-02-17 |
Track Esophageal Squamous Cell Carcinoma Abdominal Stage 0 automatically
Every clearance here is in the API, with alerts when new ones post.